Sudhakar Chintharlapalli Selected Research

Sp Transcription Factors

9/2012	Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
9/2011	Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.
8/2011	Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
7/2009	Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
7/2008	Curcumin decreases specificity protein expression in bladder cancer cells.
11/2007	The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
3/2007	Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sudhakar Chintharlapalli Research Topics

Disease

33	Neoplasms (Cancer) 01/2019 - 09/2004
14	Colonic Neoplasms (Colon Cancer) 08/2011 - 09/2004
6	Prostatic Neoplasms (Prostate Cancer) 09/2012 - 02/2007
6	Pancreatic Neoplasms (Pancreatic Cancer) 09/2010 - 07/2005
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2010 - 01/2006
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 11/2007
2	Pathologic Neovascularization 01/2019 - 01/2016
2	Pituitary Neoplasms (Pituitary Adenoma) 09/2011 - 08/2011
2	Mouth Neoplasms (Oral Cancer) 07/2010 - 03/2010
1	Neuroinflammatory Diseases 01/2020
1	Inflammation (Inflammations) 01/2020
1	Low Back Pain (Lumbago) 01/2020
1	Intervertebral Disc Degeneration 01/2020
1	Pain (Aches) 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 12/2019
1	Adenocarcinoma 01/2018
1	Neuroendocrine Carcinoma 01/2018
1	Retinal Diseases 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Neoplasm Metastasis (Metastasis) 04/2013
1	Thyroid Neoplasms (Thyroid Cancer) 09/2011
1	Colorectal Neoplasms (Colorectal Cancer) 07/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2010
1	Esophageal Neoplasms (Esophageal Cancer) 07/2009

Drug/Important Bio-Agent (IBA)

15	PPAR gammaIBA 05/2010 - 09/2004
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2007
12	Proteins (Proteins, Gene)FDA Link 09/2012 - 01/2006
7	Sp Transcription FactorsIBA 09/2012 - 03/2007
7	Pharmaceutical PreparationsIBA 09/2012 - 12/2005
6	methyl 2- cyano- 3,11- dioxo- 18beta- olean- 1,12- dien- 30- oateIBA 09/2012 - 05/2007
6	Caveolin 1IBA 05/2010 - 09/2004
5	LigandsIBA 01/2020 - 07/2005
5	SurvivinIBA 08/2011 - 03/2007
4	Monoclonal AntibodiesIBA 01/2018 - 01/2015
4	Antineoplastic Agents (Antineoplastics)IBA 11/2011 - 07/2005
4	1,1- bis(3'- indolyl)- 1- (4- t- butylphenyl)methaneIBA 07/2008 - 09/2004
3	Messenger RNA (mRNA)IBA 09/2011 - 11/2007
3	Betulinic AcidIBA 08/2011 - 03/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 07/2005
3	TriterpenesIBA 08/2009 - 03/2007
2	Angiopoietin-2IBA 01/2020 - 03/2013
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2020 - 09/2010
2	RamucirumabIBA 01/2018 - 01/2016
2	AndrogensIBA 09/2012 - 10/2007
2	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2011 - 03/2007
2	Transcription Factors (Transcription Factor)IBA 08/2011 - 03/2007
2	p38 Mitogen-Activated Protein KinasesIBA 07/2010 - 03/2010
2	tolfenamic acidIBA 07/2010 - 07/2009
2	5,5'-dibromo-1,1-bis(3'-indolyl)methaneIBA 03/2010 - 07/2008
2	Nerve Growth Factor (NGF)IBA 03/2010 - 07/2009
2	rat MIRN27 microRNAIBA 10/2009 - 11/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2009 - 07/2008
2	Glycyrrhetinic Acid (Po 12)IBA 08/2009 - 05/2007
2	PhytochemicalsIBA 08/2009 - 11/2007
2	Cyclin-Dependent Kinase Inhibitor p21IBA 07/2009 - 07/2008
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2008 - 07/2005
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2008 - 12/2005
2	EstersIBA 11/2007 - 07/2005
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2007 - 07/2005
1	IntegrinsIBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2020
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2020
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2019
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	LipidsIBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	SphingosineIBA 01/2019
1	Chromogranin AIBA 01/2018
1	SynaptophysinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	AntibodiesIBA 01/2015
1	AngiopoietinsIBA 03/2013
1	MicroRNAs (MicroRNA)IBA 09/2012
1	Sunitinib (Sutent)FDA Link 11/2011
1	N- ((5- bromo- 2- thienyl)sulfonyl)- 2,4- dichlorobenzamideIBA 11/2011
1	Histones (Histone)IBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 11/2011
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2011
1	K-18 conjugate (K18)IBA 09/2011
1	Cyclin D1IBA 08/2011
1	ErbB Receptors (EGF Receptor)IBA 08/2011
1	1,1- bis(3'- indolyl)- 1- (4- hydroxyphenyl)methaneIBA 09/2010
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 09/2010
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2010
1	indoleIBA 05/2010
1	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 03/2010
1	Orphan Nuclear ReceptorsIBA 03/2010
1	3,3'-diindolylmethane (diindolylmethane)IBA 03/2010
1	IsothiocyanatesIBA 03/2010
1	1,1-bis(3'-indolyl)-1-(p-anisyl)methaneIBA 07/2009
1	Proto-Oncogene Proteins c-metIBA 07/2009

Therapy/Procedure

5	Therapeutics 01/2019 - 12/2008
5	Drug Therapy (Chemotherapy) 01/2018 - 10/2008
1	Immunotherapy 01/2016